Emerging drug threat surveillance and early warning project
Active Cooperative Agreement Awarded
- Award ID
- RDA9926C0001
- Recipient
-
Coeur D'alene Tribal Health Authority UEI KSNKJDS7WQM3
- Awarding agency
-
Office of the National Drug Control Policy
Executive Office of the President
- Obligated
- $300,000
Award facts
- Assistance listing
- 95.007 Research and Data Analysis
- Completion date 15% complete
- Place of performance
- Idaho, USA
Award details come from USAspending.gov.
About this award
The Executive Office of the President, Office of the National Drug Control Policy, awarded Coeur D'alene Tribal Health Authority, doing business as Marimn Health, $300,000 in cooperative agreement funding on September 28, 2026, under the Research and Data Analysis program (CFDA 95.007). The award funds the Emerging Drug Threat Surveillance and Early Warning Project. The program's stated purpose is to inform policy formulation and assessment through research and analysis of data as it pertains to drug policy. The source does not describe specific deliverables beyond the project title. The full $300,000 is obligated, and the period of performance runs through September 17, 2027. Place of performance is Idaho, USA. The Office of the National Drug Control Policy is a civilian federal agency. The source names no sub-recipients for this award.
Quick answers
Who received award RDA9926C0001?
RDA9926C0001 was awarded to Coeur D'alene Tribal Health Authority by Office of the National Drug Control Policy (Executive Office of the President) on September 28, 2026.
How much is award RDA9926C0001 worth?
$300,000 has been obligated on RDA9926C0001.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award